Browsing Tag
FemBloc
1 post
FDA approval and $12m funding propel Femasys’ FemBloc toward market-ready milestone
Discover how Femasys’ FemBloc advances with FDA clearance and $12 M in funding, propelling its non-surgical birth control toward commercialization.